Atossa Therapeutics (ATOS) – Analyst Ratings
-
H.C. Wainwright Starts Atossa Genetics (ATOS) at Buy
-
Cantor Fitzgerald Starts Atossa Genetics (ATOS) at Overweight, 'Changing the Treatment Paradigm in Breast Cancer'
-
-
-
-
-
-
-
-
-
Back to ATOS Stock Lookup